Abstract B027: Programmable Raptamers enable a repeatable translational framework for pediatric cancer therapeutics
Despite being the leading disease-related cause of death in children, pediatric cancers comprise less than 1% of cancers, making drug development commercially unattractive. Multi-omics profiling has identified over 150 molecular targets, but drug development still lags substantially. Cell-surface receptors are es...